Reports available for purchase. Please note that any reports you have access to will appear below. Newsletter subscribers now have free access to all reports.
Special Report: Novartis ONLY $25.00 - Buy now
Special Report: Benitec Biopharma ONLY $25.00 - Buy now
Special Report: Our Stock for Credit Card Protection ONLY $29.95 - Buy now
Special Report: Portugal Real Estate ONLY $19.95 - Buy now
Special Report: Spain Real Estate ONLY $19.95 - Buy now
Purchase immediate access to these special reports for US$49.95 each:
Special Report: The Small Cap ADR Edge Buy now
Special Report: ETFs Buy now
Special Report: China Buy now
Special Report: Royal Bank of Scotland Buy now
Reports that you have purchased access to appear below.
US Investing Abroad, A Special Report
March 30, 2009 By Paul A. Renaud. www.thaistocks.com
Investing in Emerging Markets by individual investors based in developed countries.
Buying foreign shares in an emerging country, from within a developed country, is always more expensive commission wise and perhaps otherwise. Many US residents currently know they got to get going internationally, but are understandably naïve on how to implement this. Or have done this but in a less then optimal way. Here below I elaborate on this theme, as seen from the benefits derived as viewed from individual